Camila Gemin Ribas1, Letícia Alves da Silva1, Marina Ribas Corrêa1, Hélio Ghizone Teive2, Silvia Valderramas3. 1. Department of Physical Therapy, Universidade Federal Do Paraná (UFPR), Curitiba, Paraná, Brazil. 2. Department of Neurology, Universidade Federal Do Paraná (UFPR), Curitiba, PR, Brazil. 3. Department of Neurology, Universidade Federal Do Paraná (UFPR), Curitiba, PR, Brazil. Electronic address: svalderramas@uol.com.br.
Abstract
Although motor symptoms in Parkinson's disease (PD) are well established, few studies have described the effects of exergaming on the clinical and functional outcomes of PD. OBJECTIVES: To analyze the effectiveness of exergaming in improving functional balance, fatigue, functional exercise capacity and quality of life in PD. METHODS: The study population consisted of 20 patients (12 males and 8 females) aged 61 ± 9.11 years allocated into two groups: anexergaming group (EGG) (n = 10) and a conventional exercise, or control, group (CG) (n = 10). The following variables were evaluated: functional balance (Berg Scale), fatigue (Fatigue Severity Scale), functional exercise capacity (Six-Minute Walk Test) and quality of life (PDQ-39 Quality of Life Questionnaire). RESULTS: RM-ANOVA showed that balance and fatigue differed significantly between time points: balance [F(1.29, 23.33) = 4.16, p = 0.043] and fatigue [F(2,36) = 5.96, p = 0.006]. In both cases post hoc Bonferroni testing revealed an improvement after 12 weeks of exergaming (p = 0.033 and p = 0.000, respectively). However, this benefit was not sustained after 60 days of follow-up for either outcome. There were no differences in functional exercise capacity or quality of life between the two groups after 12 weeks of treatment. CONCLUSION: Exergaming was effective in enhancing balance and reducing fatigue in PD patients after 12 weeks of treatment, but this benefit was not sustained in the long-term.
RCT Entities:
Although motor symptoms in Parkinson's disease (PD) are well established, few studies have described the effects of exergaming on the clinical and functional outcomes of PD. OBJECTIVES: To analyze the effectiveness of exergaming in improving functional balance, fatigue, functional exercise capacity and quality of life in PD. METHODS: The study population consisted of 20 patients (12 males and 8 females) aged 61 ± 9.11 years allocated into two groups: an exergaming group (EGG) (n = 10) and a conventional exercise, or control, group (CG) (n = 10). The following variables were evaluated: functional balance (Berg Scale), fatigue (Fatigue Severity Scale), functional exercise capacity (Six-Minute Walk Test) and quality of life (PDQ-39 Quality of Life Questionnaire). RESULTS: RM-ANOVA showed that balance and fatigue differed significantly between time points: balance [F(1.29, 23.33) = 4.16, p = 0.043] and fatigue [F(2,36) = 5.96, p = 0.006]. In both cases post hoc Bonferroni testing revealed an improvement after 12 weeks of exergaming (p = 0.033 and p = 0.000, respectively). However, this benefit was not sustained after 60 days of follow-up for either outcome. There were no differences in functional exercise capacity or quality of life between the two groups after 12 weeks of treatment. CONCLUSION: Exergaming was effective in enhancing balance and reducing fatigue in PDpatients after 12 weeks of treatment, but this benefit was not sustained in the long-term.
Authors: Jacqueline A Osborne; Rachel Botkin; Cristina Colon-Semenza; Tamara R DeAngelis; Oscar G Gallardo; Heidi Kosakowski; Justin Martello; Sujata Pradhan; Miriam Rafferty; Janet L Readinger; Abigail L Whitt; Terry D Ellis Journal: Phys Ther Date: 2022-04-01
Authors: S Bonavita; L Lavorgna; G Abbadessa; F Brigo; M Clerico; S De Mercanti; F Trojsi; G Tedeschi Journal: J Neurol Date: 2021-05-20 Impact factor: 4.849
Authors: Gisele Cristine Vieira Gomes; Jéssica Maria Ribeiro Bacha; Maria do Socorro Simões; Sumika Mori Lin; Larissa Alamino Pereira Viveiro; Eliana Maria Varise; Wilson Jacob Filho; José Eduardo Pompeu Journal: Pilot Feasibility Stud Date: 2017-10-24
Authors: Daniel Tough; Jonathan Robinson; Steven Gowling; Peter Raby; John Dixon; Samantha L Harrison Journal: BMC Cancer Date: 2018-11-21 Impact factor: 4.430